Profil de l'entreprise

Vous venez de lire:

ELIQUIS® approved for treatment of venous thromboembolic events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and prevention of recurrent DVT and PE

Nouvelles fournies par

Pfizer Canada Inc.

Nov 26, 2014, 07:59 ET